Product Information
IMIQUIMOD 3.75% CREAM PUMP is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $113.1215 per GM under NDC 00093313331. Its NADAC has been published 83 times since Apr 17, 2024.
FDA first approved this application on Mar 25, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
37.5 mg/g
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093313331
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
IMIQUIMODApproval Type
Authorized Generic (NDA)
FDA Application
NDA022483FDA Approved
3/25/2010
TE Code
AB
On Market Since
7/30/2020
Pharmacological Classes
Price Statistics
The NADAC for IMIQUIMOD 3.75% CREAM PUMP has been published 83 times since Apr 17, 2024, and over the history we have for it it has risen 190.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $113.1215 per GM |
|---|---|
| All-time high | $118.6295 (May 13, 2026) |
| All-time low | $20.3957 (Jul 17, 2024) |
| 52-week high | $118.6295 |
| 52-week low | $107.0427 |
| Median price | $24.6610 |
| Average price | $60.4079 |
| Largest weekly change | +382.9% (Feb 18, 2026) |
| Weeks tracked | 83 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 78% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
imiquimod market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of IMIQUIMOD 3.75% CREAM PUMP?
The current National Average Drug Acquisition Cost (NADAC) for IMIQUIMOD 3.75% CREAM PUMP, manufactured by Teva Pharmaceuticals USA Inc., is $113.1215 per GM (NDC 00093313331), effective Sep 30, 2026.
How has the price of IMIQUIMOD 3.75% CREAM PUMP changed over time?
Over the history we have for it, the NADAC for IMIQUIMOD 3.75% CREAM PUMP has risen 190.1%. It has been tracked across 83 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for IMIQUIMOD 3.75% CREAM PUMP?
Since Apr 17, 2024, the NADAC for IMIQUIMOD 3.75% CREAM PUMP has ranged from a low of $20.3957 (Jul 17, 2024) to a high of $118.6295 (May 13, 2026), with a median of $24.6610 per GM.
Are there cheaper alternatives to IMIQUIMOD 3.75% CREAM PUMP?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IMIQUIMOD 3.75% CREAM PUMP, is $24.3913 per GM — about 78% below IMIQUIMOD 3.75% CREAM PUMP.
Who manufactures IMIQUIMOD 3.75% CREAM PUMP?
IMIQUIMOD 3.75% CREAM PUMP (NDC 00093313331) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.